René G P van Gennip Selected Research

Bluetongue

10/2021	Pentavalent Disabled Infectious Single Animal (DISA)/DIVA Vaccine Provides Protection in Sheep and Cattle against Different Serotypes of Bluetongue Virus.
1/2021	The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVA.
1/2017	Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep.
10/2015	Development of a competitive ELISA for NS3 antibodies as DIVA test accompanying the novel Disabled Infectious Single Animal (DISA) vaccine for Bluetongue.
9/2015	VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
12/2014	VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
9/2014	Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge.
4/2010	Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

René G P van Gennip Research Topics

Disease

8	Bluetongue 10/2021 - 04/2010
3	Viremia 01/2018 - 12/2014
2	Infections 08/2016 - 12/2014
1	African Horse Sickness (African Horsesickness) 01/2018

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 10/2021 - 04/2010
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2016
2	AntibodiesIBA 10/2015 - 12/2014
1	Amino Acids FDA Link 01/2018
1	Inactivated VaccinesIBA 01/2017